Bausch Health Companies Inc. (TSX:BHC)
8.83
+0.09 (1.03%)
Jun 27, 2025, 4:00 PM EDT
Bausch Health Companies Revenue
Bausch Health Companies had revenue of $2.26B USD in the quarter ending March 31, 2025, with 4.92% growth. This brings the company's revenue in the last twelve months to $9.73B, up 8.53% year-over-year. In the year 2024, Bausch Health Companies had annual revenue of $9.63B with 9.91% growth.
Revenue (ttm)
$9.73B
Revenue Growth
+8.53%
P/S Ratio
0.23
Revenue / Employee
$470.10K
Employees
20,700
Market Cap
3.23B CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.63B | 868.00M | 9.91% |
Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sienna Senior Living | 896.45M |
Green Thumb Industries | 1.64B |
dentalcorp Holdings | 1.58B |
Extendicare | 1.47B |
Cronos Group | 179.08M |
WELL Health Technologies | 990.34M |
Trulieve Cannabis | 1.71B |
Curaleaf Holdings | 1.89B |
Bausch Health Companies News
- 1 day ago - Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility - Business Wire
- 5 days ago - A Billionaire Trump Supporter Is Buying These Two Stocks - Barrons
- 9 days ago - Bausch Health Shares Rise as Nonexecutive Chairperson Paulson Buys $21.2M in Shares - Market Watch
- 11 days ago - Repricing Potential Driven By Deleveraging - Seeking Alpha
- 14 days ago - Bausch Health ticks higher following large director stock purchase - Seeking Alpha
- 23 days ago - Bausch + Lomb Launches Blink® Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the United States - Business Wire
- 5 weeks ago - Facial Injectable Market Forecasts Report 2025-2030, Competitive Analysis of Key Players - Allergan, Bausch Health, Bloomage Biotechnology, and Galderma - GlobeNewsWire
- 5 weeks ago - Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States - Business Wire